Skip to main content
    I

    Illumina Inc (ILMN)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $202.61
    +4.61 (+2.33%)

    Market Cap: $29.94B

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Illumina Inc (ILMN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Illumina (ILMN) has a market cap of $29.94B and an enterprise value of $30.44B. Its trailing P/E of 38.6x is below its 10-year median of 56.7x. Its return on invested capital of 19.12% compares with a 8.20% median across 11 similar companies.

    Total Valuation

    Enterprise value is 1.67% above the market cap, as debt exceeds cash.

    Market Cap$29.94B
    Enterprise Value$30.44B
    Latest price (Nov 17, 2026)$202.61

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and shrank 2.55% a year over 2 years.

    Shares Outstanding151.00M
    Shares Change (YoY)-1.31%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)-2.55%

    Valuation Ratios

    Sales and book value multiples are 6.7x and 9.7x. Its year-end P/E ranged from 27.0x to 160.0x from 2016 to 2025.

    P/E Ratio38.6x
    Forward P/E36.6x
    P/S Ratio6.7x
    Forward P/S6.5x
    P/B Ratio9.7x
    P/TBV Ratio20.8x
    P/FCF Ratio28.9x
    P/OCF Ratio24.3x
    PEG Ratio2.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 22.3x EBITDA and 29.4x free cash flow.

    EV / Earnings34.0x
    EV / Sales6.7x
    EV / EBITDA22.3x
    EV / EBIT27.3x
    EV / FCF29.4x

    Price Statistics

    The stock is up 67.90% over 52 weeks and trades 18.45% below its 50-day average.

    Beta (1Y)1.12
    52-Week Change+67.90%
    1-Month Change-22.86%
    3-Month Change-1.17%
    6-Month Change+43.01%
    5-Year Change-43.14%
    10-Year Change+73.34%
    Total Return (1Y)+67.90%
    Total Return (3Y CAGR)+30.21%
    Total Return (5Y CAGR)-11.15%
    Return vs SPY (1Y)+54.56%
    Max Drawdown (1Y)-32.58%
    Max Drawdown (3Y)-54.69%
    Sharpe Ratio (1Y)1.03
    Correlation with SPY (1Y)0.31
    50-Day Average$248.45
    200-Day Average$180.09
    52-Week Range$112.65 to $309.35
    RSI (14 Days)35.0
    Average Volume (20 Days)2.21M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.63x current liabilities, and total debt is 0.57x shareholder equity.

    Current Ratio2.63x
    Quick Ratio2.05x
    Debt / Equity0.57x
    Debt / EBITDA1.28x
    Debt / FCF1.69x
    Interest Coverage11.39x

    Returns and Efficiency

    Return on invested capital is 19.12% over the last 12 months, against a 5-year average of -12.33%.

    Return on Equity (ROE)28.46%
    Return on Assets (ROA)13.14%
    Return on Invested Capital (ROIC)19.12%
    Return on Capital Employed (ROCE)19.73%
    ROE (5Y Average)-20.03%
    ROA (5Y Average)-9.81%
    ROIC (5Y Average)-12.33%
    Asset Turnover0.70x
    Inventory Turnover2.25x
    Receivables Turnover6.04x
    Cash Conversion Cycle164 days

    Taxes

    Income tax took 15.49% of pretax income over the last 12 months.

    Income Tax (TTM)$164.00M
    Effective Tax Rate15.49%

    Scores

    ILMN has an Altman Z-Score of 6.58, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.

    Altman Z-Score6.58
    Altman Z ZoneSafe
    Piotroski F-Score8 of 9
    Piotroski StrengthStrong

    Income Statement

    Revenue of $4.54B over the last 12 months is up 5.83% from the 12 months before.

    Revenue$4.54B
    Revenue Growth (YoY)+5.83%
    Gross Profit$3.08B
    Operating Income$961.00M
    Pretax Income$1.06B
    Net Income$895.00M
    EBITDA$1.39B
    EBIT$1.12B
    Reported EPS (TTM)$5.25

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 46.26% of the $6.81B in total assets.

    Cash and Equivalents$1.29B
    Total Debt$1.79B
    Net Debt$500.00M
    Net Debt Per Share$3.31
    Working Capital$1.88B
    Shareholder Equity$3.15B
    Book Value Per Share$20.83
    Tangible Book Value$1.47B
    Tangible Book Per Share$9.74
    Total Assets$6.81B
    Total Liabilities$3.67B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $173.00M of capital spending, operating cash flow left $1.06B of free cash flow.

    Operating Cash Flow$1.23B
    Capital Expenditures$173.00M
    Free Cash Flow$1.06B
    FCF Per Share$7.00
    Depreciation and Amortization$277.00M
    Share Repurchases$421.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 21.18%, against a 5-year average of -23.62%.

    Gross Margin67.87%
    Operating Margin21.18%
    Pretax Margin23.34%
    Net Margin19.72%
    EBITDA Margin30.70%
    EBIT Margin24.59%
    FCF Margin23.29%
    Gross Margin (5Y Average)65.39%
    Operating Margin (5Y Average)-23.62%
    Net Margin (5Y Average)-22.68%

    Growth

    Revenue fell 1.78% a year over 3 years, and EPS grew 31.77% a year.

    Revenue Growth (3Y CAGR)-1.78%
    Revenue Growth (5Y CAGR)+6.04%
    EPS Growth (3Y CAGR)+31.77%
    EPS Growth (5Y CAGR)+1.51%
    FCF Growth (3Y CAGR)+106.32%
    FCF Growth (5Y CAGR)+0.88%
    Book Value Per Share Growth (2Y CAGR)-30.05%
    Tangible Book Per Share Growth (2Y CAGR)+164.25%

    Revenue and profit by year

    Dividends and Yields

    ILMN does not pay a dividend. Its free cash flow yield is 3.45%.

    Earnings Yield2.59%
    FCF Yield3.45%
    Buyback Yield1.23%

    Stock Splits

    The last split was a 2-for-1 forward split on Sep 23, 2008.

    Last Split DateSep 23, 2008
    Split TypeForward split
    Split Ratio2:1

    Peer Position

    Against 11 similar companies, ILMN has the 2nd highest P/E and the 3rd highest ROIC.

    P/E Ratio38.6x vs 26.6x median
    P/S Ratio6.7x vs 5.2x median
    ROIC19.12% vs 8.20% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.83% vs +7.56% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.86% and EPS growth at 12.91% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.86%
    EPS Growth Forecast (2Y CAGR)+12.91%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ILMN

    What is ILMN's market cap?

    Illumina has a market cap of $29.94B. Its enterprise value, which adds debt and subtracts cash, is $30.44B.

    What is ILMN's P/E ratio?

    Illumina has a trailing P/E ratio of 38.6x and a forward P/E of 36.6x.

    How many shares of ILMN are outstanding?

    Illumina has 151.00M shares outstanding. The count is down 1.31% from a year earlier.

    Does ILMN pay a dividend?

    No. Illumina does not pay a dividend.

    How much debt does ILMN have?

    Illumina has $1.79B of total debt and $1.29B of cash and equivalents, a net debt position of $500.00M.